Geographic Atrophy Clinical Trials

Find Geographic Atrophy Clinical Trials Near You

Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This study is being conducted to assess two imaging methods-central microperimetry and radial OCT (Optical Coherence Tomography)-in patients with Geographic Atrophy (GA) or those who are at risk of developing this condition. The study team is trying to determine whether these methods can provide more accurate measurements of GA progression toward the foveal center, the central part of the retina responsible for your sharpest, most detailed vision.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Healthy Volunteers: f
View:

• Subjects must be 55+ years of age Subjects in the Intermediate AMD Observation Arm must have intermediate age-related macular degeneration in one eye

⁃ Subjects in the GA Observation Arm, GA Continuing Treatment Arm, and GA Treatment Arm must have non-central GA (defined as GA has not involved the center point of the fovea) and at least 1% GA in the central 1 mm zone.

Locations
United States
California
University of California, San Francisco
RECRUITING
San Francisco
Contact Information
Primary
Jay M Stewart, MD
eyestudy@ucsf.edu
(628) 206-3123
Time Frame
Start Date: 2025-06-11
Estimated Completion Date: 2027-06-11
Participants
Target number of participants: 80
Treatments
Non-central geographic atrophy not being treated
Patients with age-related macular degeneration who have geographic atrophy that does not involve the fovea.
Intermediate age-related macular degeneration
Patients with intermediate age-related macular degeneration
Non-central geographic atrophy currently being treated
Patients with non-central geographic atrophy from age-related macular degeneration who are currently receiving treatment for this condition.
Non-central geographic atrophy initiating treatment
Patients with non-central geographic atrophy from age-related macular degeneration who will be starting to receive treatment for this condition.
Sponsors
Leads: University of California, San Francisco

This content was sourced from clinicaltrials.gov

Similar Clinical Trials